Skip to main content
LFVN $6.57 +1.23%
LFVN logo

LFVN · Lifevantage Corp

Track LFVN — free
$6.57 +0.08 (+1.23%) At close · Aug 14
Market Cap
$82.89M
Shares
12.62M
All earnings calls

Earnings call · FY2025 Q1

Lifevantage Corp Q1 FY2025 Earnings Call

Lifevantage Corp Q1 FY2025 Earnings Call

Concluded Oct 29, 2024
Oct 29, 2024 0 turns
Period
FY2025 Q1
Runtime
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $47.21M -8.1% YoY
Diluted EPS $0.14 +180% YoY
Gross margin 79.9% -0.3 pp YoY
Net income $1.83M +190.3% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Protandim$24.20M
LifeVantage True Science Skin Care Regimen$12.79M
TrueScience Product Line$3.90M
AXIO Product Line$3.53M
PhysIQ Product Line$1.14M
Product And Service Other$1.11M
Petandim Product Line$534,000

Capital returned

Buybacks
$1.11M
Shares repurchased
100,000
Dividend / share
$0.04
Full-screen source Call document